Canary Capital's INJC launches on Nasdaq as the first U.S. ETF for INJ, with staking built in. The fund aims to stake up to 90% of its INJ holdings and automatically restake net staking rewards.
INJC gives brokerage-account investors direct INJ exposure through a regulated fund, opening a new demand channel for the token. Staking a large share of the fund's holdings can also take those tokens out of circulating supply.
Injective 🥷@injectiveToday, INJ just made history.$INJC, the first U.S. ETF for $INJ, is now live on @Nasdaq with staking built in.
A new era of Injective begins now 🧵 pic.twitter.com/hBOff3BtKQ
Nov 05, 2026
Today, INJ just made history.$INJC, the first U.S. ETF for $INJ, is now live on @Nasdaq with staking built in.
A new era of Injective begins now 🧵 pic.twitter.com/hBOff3BtKQ
